Literature DB >> 7728385

Host-range control of a retroviral disease: Friend erythroleukemia.

M E Hoatlin1, D Kabat.   

Abstract

Since its discovery in 1957, Friend viral erythroleukemia has been the major model for understanding host genetic barriers to retroviral diseases and has facilitated the discovery of many polymorphic leukemia-control genes of mice. Some of these genes limit helper-virus replication, target-cell (erythroblast) pools or immune responses. At least one host gene appears to block the viral oncoprotein.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7728385     DOI： 10.1016/s0966-842x(00)88875-7

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  19 in total

1.  Kinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.

Authors:  U Dittmer; B Race; K J Hasenkrug
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Effective postexposure treatment of retrovirus-induced disease with immunostimulatory DNA containing CpG motifs.

Authors:  Anke R M Olbrich; Simone Schimmer; Klaus Heeg; Koen Schepers; Ton N M Schumacher; Ulf Dittmer
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Friend virus utilizes the BMP4-dependent stress erythropoiesis pathway to induce erythroleukemia.

Authors:  Aparna Subramanian; Shailaja Hegde; Prashanth Porayette; Michele Yon; Pamela Hankey; Robert F Paulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 4.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression.

Authors:  Ulf Dittmer; Brent Race; Karin E Peterson; Ingunn M Stromnes; Ronald J Messer; Kim J Hasenkrug
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain.

Authors:  S N Constantinescu; X Liu; W Beyer; A Fallon; S Shekar; Y I Henis; S O Smith; H F Lodish
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

7.  Role of interleukin-4 (IL-4), IL-12, and gamma interferon in primary and vaccine-primed immune responses to Friend retrovirus infection.

Authors:  U Dittmer; K E Peterson; R Messer; I M Stromnes; B Race; K J Hasenkrug
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Preinfection treatment of resistant mice with CpG oligodeoxynucleotides renders them susceptible to friend retrovirus-induced leukemia.

Authors:  Anke R M Olbrich; Simone Schimmer; Ulf Dittmer
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.

Authors:  K J Hasenkrug; D M Brooks; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.